Jeff Geschwind, MD: Pioneering Cancer Drug Development Jeff Geschwind, MD, founded Cage Pharma to target cancer metabolism. His research focuses on glycolysis inhibition, opening new pathways for innovative cancer drug development. https://www.linkedin.com/in/jeff-geschwind-037200174